224 related articles for article (PubMed ID: 12811301)
1. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis.
Elefsiniotis IS; Diamantis ID; Dourakis SP; Kafiri G; Pantazis K; Mavrogiannis C
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):721-6. PubMed ID: 12811301
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of anticardiolipin antibodies in chronic hepatitis B infection together with total anti-delta positivity].
Meşe S; Ozekinci T; Atmaca S; Arikan E; Akin D
Mikrobiyol Bul; 2008 Jul; 42(3):483-7. PubMed ID: 18822893
[TBL] [Abstract][Full Text] [Related]
3. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
4. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis D virus antigen in HBsAg positive chronic liver disease in Nigeria.
Ojo OS; Akonai AK; Thursz M; Ndububa DA; Durosinmi MA; Adeodu OO; Fatusi OA; Goldin RD
East Afr Med J; 1998 Jun; 75(6):329-31. PubMed ID: 9803613
[TBL] [Abstract][Full Text] [Related]
7. Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders.
Baig S; Siddiqui AA; Ahmed WU; Qureshi H; Arif A
J Coll Physicians Surg Pak; 2009 Nov; 19(11):699-703. PubMed ID: 19889265
[TBL] [Abstract][Full Text] [Related]
8. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
[TBL] [Abstract][Full Text] [Related]
9. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection.
Sezaki H; Kobayashi M; Hosaka T; Someya T; Akuta N; Suzuki F; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Sato J; Kumada H
J Gastroenterol; 2004 Jun; 39(6):550-6. PubMed ID: 15235872
[TBL] [Abstract][Full Text] [Related]
11. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin antibodies in patients with liver disease.
Mangia A; Margaglione M; Cascavilla I; Gentile R; Cappucci G; Facciorusso D; Grandone E; Di Minno G; Rizzetto M; Andriulli A
Am J Gastroenterol; 1999 Oct; 94(10):2983-7. PubMed ID: 10520856
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus DNA in patients with hepatitis B-related liver cirrhosis with or without hepatocellular carcinomas: a matched case-control study.
Xu J; Lin Y; Wang YP; Chen YX; Shi B; Lu J; Xie WF
J Dig Dis; 2009 May; 10(2):138-44. PubMed ID: 19426397
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
16. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
[TBL] [Abstract][Full Text] [Related]
17. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
[TBL] [Abstract][Full Text] [Related]
18. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses.
Oyunsuren T; Kurbanov F; Tanaka Y; Elkady A; Sanduijav R; Khajidsuren O; Dagvadorj B; Mizokami M
J Med Virol; 2006 Dec; 78(12):1688-95. PubMed ID: 17063518
[TBL] [Abstract][Full Text] [Related]
19. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
20. [Serum hepatitis B antigen-antibody system in patients with hepatocellular carcinoma].
Wu A; Cheng G
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):441-3. PubMed ID: 8697998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]